Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by Walterthedogon Dec 04, 2020 11:10am
81 Views
Post# 32036907

RE:Achievements

RE:AchievementsI agree we have achieved a fair bit of legitimacy and 10 cents is a fair value for the company as it stands. 3.5:1 PS ratio. 2:1 asset to debt and we are only losing 250 000$ per quarter which isn't far from profitability. The reason many of us may have valued the company too high over the years is in large part due to the torrent of promises and plans that evaporated either due to changing legislation or just incompetence or whatever. Greenhouse in Ont, shipping clones across the country, purchasing a wholesaler in Austrailia, shipments to Germany, growing pot in Lesotho, starting our own retail chain, creating 5000 sticks per minute for other producers and many many more. I realize you can't take what a company says at face value but at some point there is some onus on the company and bagholders have every right to be sour. That being said, the few that are still here obviously still see potential or they would have sold (or there is just nothing left of their investment to withdraw). Sauntering in at this point and claiming you can correctly value the company when we couldn't is supremely arrogant and hindsight is always 20/20. There is no point in whining about our loss but shareholders have every right to be upset. I took a tour of the company in 2018 and they told me we were way undervalued at the then price of .26$. Guess not. The battle for market share has become more brutal than most of us could have foreseen and it took us so long to get our production up to speed that we missed an opportunity to make our mark. Will the same thing happen with 2.0? KISS should be our focus right now and im glad JM is redesigning the bottle. Hopefully we see a price drop as well. Also i think they should consider upsizing the bottle size. The only complaint ive seen in reviews is that it tastes great and folks wish there was more. Lol. Not hard to fix that.
<< Previous
Bullboard Posts
Next >>